✦ LIBER ✦

Targeted tumor therapy with the TGF-β2 antisense compound AP 12009

✍ Scribed by Karl-Hermann Schlingensiepen; Reimar Schlingensiepen; Andreas Steinbrecher; Peter Hau; Ulrich Bogdahn; Birgit Fischer-Blass; Piotr Jachimczak

Book ID: 116400997
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 883 KB
Volume: 17
Category: Article
ISSN: 1359-6101
DOI: 10.1016/j.cytogfr.2005.09.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immuno-gene therapy of rat glioma with T

Immuno-gene therapy of rat glioma with TGF-β2 antisense and IL-2 gene modified tumor cells

✍ RE Sobol; O Dorigo; DL Shawler; H Lin; I Royston; H Fakhrai 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 146 KB

439 TGF-beta2 suppression by the antisen

439 TGF-beta2 suppression by the antisense oligonucleotide AP 12009 as therapy for high-grade glioma: safety and efficacy results of phase I/II clinical studies

✍ K. Schlingensiepen; P. Hau; A. Brawanski; J. Schlaier; M. Mehdorn; G. Wurm; J. P 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 293 KB